Therapy-related myeloid neoplasms following treatment with radioiodine. - Wikidata - awgldk - TriplyDB

Therapy-related myeloid neoplasms following treatment with radioiodine.

Therapy-related myeloid neoplasms following treatment with radioiodine.

http://www.wikidata.org/entity/Q35717790

about

Myelodysplastic syndromes: diagnosis, prognosis, and treatment.A case of therapy-related acute myeloid leukemia with inv(16)(p13.1q22) after single low-dose iodine-131 treatment for thyroid cancer Frequent induction of chromosomal aberrations in in vivo skin fibroblasts after allogeneic stem cell transplantation: hints to chromosomal instability after irradiation.Clinical features and prognosis of patients with myelodysplastic syndromes who were exposed to atomic bomb radiation in Nagasaki.Role of gambogic acid and NaI131 in A549/DDP cells.Radioprotective agents for the prevention of side effects induced by radioiodine-131 therapy.A focused review of hematopoietic neoplasms occurring in the therapy-related setting.Therapy-related acute myeloid leukemia following radioactive iodine treatment for thyroid cancer.Protective effects of curcumin against genotoxicity induced by 131-iodine in human cultured lymphocyte cells.Genotoxicity induced by iodine-131 in human cultured lymphocytes.Acute leukemia arising after radioiodine treatment for thyroid cancer.Resveratrol mitigates genotoxicity induced by iodine-131 in primary human lymphocytes.Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors.Reply to “Acute leukemia arising after radioiodine treatment for thyroid cancer” Haematologica 2012;97(8):e28–29.Repeated adjuvant anti-CEA radioimmunotherapy after resection of colorectal liver metastases: Safety, feasibility, and long-term efficacy results of a prospective phase 2 study.Guidelines for the management of thyroid cancer

P2860

Q34389508-61A9D096-CAD6-4FF2-8EF1-14C79E5C11FF Q36297677-86D8FA01-FC06-407F-B4D1-A454572E8893 Q36416779-8EAE238C-EEB4-41C0-BFCB-20C1C9402F3A Q37375278-48D9FBF9-35A7-42E6-AE5B-FD6BB25746C4 Q37594133-8BEAD644-604A-4A6F-B3FB-08B34256606C Q38125502-B0A9DD27-7DCF-45CB-961C-319DDBC90DFB Q38239675-F1B55E65-AFFF-4097-98FA-C52940BD0C1F Q38603374-0BB2AFC2-D160-4BFC-AF89-C87FD3080572 Q40409652-8C08C0ED-2ADA-4016-A28C-FBCE9DE33331 Q42683054-D230C97E-D286-40FA-B5CB-CC23CFA552C7 Q43235078-6C5F650D-3F4D-4006-9DD2-280D00E48944 Q44240636-B5A529A5-816E-4C8A-991C-8D838263E394 Q44355651-E87693FC-ED4A-44C3-8AE7-0B861700CA79 Q46488151-57CE98D2-2791-4F79-A7C8-103ED5F25D62 Q47658039-174C89A5-E5BD-458A-801F-51D054F11DA3 Q56554243-ED88770A-F5EF-4CE5-B39F-BA79D6AAE4FA

P2860

Therapy-related myeloid neoplasms following treatment with radioiodine.

http://www.wikidata.org/entity/Q35717790

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Therapy-related myeloid neoplasms following treatment with radioiodine.

@ast

Therapy-related myeloid neoplasms following treatment with radioiodine.

@en

type

label

Therapy-related myeloid neoplasms following treatment with radioiodine.

@ast

Therapy-related myeloid neoplasms following treatment with radioiodine.

@en

prefLabel

Therapy-related myeloid neoplasms following treatment with radioiodine.

@ast

Therapy-related myeloid neoplasms following treatment with radioiodine.

@en

P1433

Q35717790-4794706E-E98D-45CE-91D2-D790F8D3F675

P1476

Q35717790-7C86E80C-DBB5-40A8-820C-C1B2B13901EA

P2093

Q35717790-0B152200-B4F0-4A59-A980-3A863938FF5C

Q35717790-141CD2A1-D670-4667-A4A7-15DDBC225D07

Q35717790-1F294CD5-B1B7-433B-AD57-5405F1CDB997

Q35717790-25EABC2E-E85E-4378-9AAE-F9F78E164FDB

Q35717790-286F8971-FCCB-4B2F-B649-49E0FCF53A24

Q35717790-2BC69706-E73F-4448-9BCD-67C181D2323C

Q35717790-5E6B5E69-D884-4E3E-A33C-F52130A7DFB1

Q35717790-69F00719-B3CC-444C-9C05-7578AB4A9382

Q35717790-6C4BE0F3-9930-4189-A8E7-E933089D0205

Q35717790-8A15DCBD-50FE-4D01-A4EA-421259CB3654

P2860

Q35717790-01C3B21C-DEB6-4410-A1E7-0E7DE9900A01

Q35717790-057A0BB9-6DBB-48CF-B85D-F8C14F00280F

Q35717790-0653FD35-07FA-463F-9552-E8D11DB72C02

Q35717790-15A1FB8B-BB6D-4832-A1D3-B874CED7F515

Q35717790-24AB1024-F43C-4224-9D66-7CB3D4745FDE

Q35717790-3B6B9653-39E6-4427-BD05-0D613EEE7B45

Q35717790-4D54F215-E4C7-467E-9772-0EE7975ACF34

Q35717790-4EB63EB1-E115-458B-8A68-9F8EC72758E2

Q35717790-5B4F78DD-E3D7-49F9-B4C7-480FED7B2502

Q35717790-657C02F7-403B-47B8-A42D-C829D2E0E1A8

P304

Q35717790-6A8F36A0-B128-41DD-95A5-C520FDC99B6A

P31

Q35717790-505036BF-5F5F-4E86-A313-4315275C4708

P356

Q35717790-6737C87C-83B6-48A3-B526-5D9C0D1BC47B

P433

Q35717790-930BA5AD-B3AE-4784-9904-12902D66F4A3

P478

Q35717790-AF72F298-727C-422E-8A15-ECC12FFAE4A2

P50

Q35717790-567CE31E-3BB5-4270-B93A-F0F1BE31B6F0

Q35717790-B55BF79E-F484-43D3-BAA8-E6FDB92745C9

Q35717790-C44AC2DE-59B2-4F82-A458-B6A52A9DE1B9

P577

Q35717790-A36E9BC6-D95E-4E49-8E5D-388450CFA383

P5875

Q35717790-1F87F885-C34A-4F9D-B16A-78888F5DADE8

P698

Q35717790-A5E0562D-2E58-4583-B0C3-79CAD42DD20A

P932

Q35717790-9497B531-23C4-440F-B8AB-150F851EDE34

P356

HAEMATOL.2011.049114

P1433

P1476

Therapy-related myeloid neoplasms following treatment with radioiodine.

@en

P2093

Akos G Czibere

http://www.w3.org/2001/XMLSchema#string

Andrea Kuendgen

http://www.w3.org/2001/XMLSchema#string

Detlef Haase

http://www.w3.org/2001/XMLSchema#string

Fabian Zohren

http://www.w3.org/2001/XMLSchema#string

Friederike Braulke

http://www.w3.org/2001/XMLSchema#string

Guido Kobbe

http://www.w3.org/2001/XMLSchema#string

Ingmar Bruns

http://www.w3.org/2001/XMLSchema#string

Michael Stadler

http://www.w3.org/2001/XMLSchema#string

Nicolaus Kröger

http://www.w3.org/2001/XMLSchema#string

Rainer Haas

http://www.w3.org/2001/XMLSchema#string

P2860

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

RUNX1 mutations in acute myeloid leukemia: results from a comprehensive genetic and clinical analysis from the AML study group.

Therapy-related myeloid neoplasms: pathobiology and clinical characteristics

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

Current and emerging treatment options for Graves' hyperthyroidism.

Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series.

Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia.

Therapy-related acute promyelocytic leukemia after treatment with radioiodine for thyroid cancer: case report with literature review.

Therapy-related myeloid leukemia.

The carcinogenic effects of radioiodine therapy for thyroid carcinoma.

P304

206-212

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2011.049114

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P50

Norbert Gattermann

Uwe Platzbecker

P577

2011-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51714117

http://www.w3.org/2001/XMLSchema#string

P698

21993688

http://www.w3.org/2001/XMLSchema#string

P932

3269479

http://www.w3.org/2001/XMLSchema#string